Literature DB >> 33488213

In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives.

Afnan Ahmed Alghamdi1, Mohammad Mahboob Alam1, Syed Nazreen1.   

Abstract

In the present work, a library of fifteen 2-hydroxy benzothiazole-linked 1,3,4 -oxadiazole derivatives have been synthesized and confirmed using different analytical techniques. All of the synthesized compounds have been tested for antibacterial and in silico pharmacokinetic studies for the first time. From the ADME predictions, compound 4 showed the highest in silico absorption percentage (86.77%), while most of the compounds showed more than 70% absorption. All of the compounds comply with the Lipinski rule of 5, suggesting that the compounds possess good drug likeness properties upon administration. Furthermore, all of the compounds follow the Veber rule, indicating good bioavailability and good intestinal absorption. The antibacterial results exhibited excellent to moderate activity. Compounds 5 , 9 , 12 , 14 , 15 , 16 , and 17 were the most active compounds against the tested bacterial strains. Compound 14 showed comparable MIC 6.25 ±0.2 μg/disc to the standard drug amoxicillin against the tested Gram-positive bacterial strains. Compounds 5 , 14 , 17 exhibited MIC 12.5 ±0.8 μg/disc, which was comparable to the standard drug against E. faecalis . It can be concluded that the synthesized compound could be used as a lead molecule in the development of new antibacterial agents with high efficacy.
Copyright © 2020 The Author(s).

Entities:  

Keywords:  Heterocycles; minimum inhibitory concentration; pharmacokinetics

Year:  2020        PMID: 33488213      PMCID: PMC7751938          DOI: 10.3906/kim-1912-55

Source DB:  PubMed          Journal:  Turk J Chem        ISSN: 1300-0527            Impact factor:   1.239


  18 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring.

Authors:  A K Mohammed Iqbal; Ashraf Y Khan; Mallikarjun B Kalashetti; Ningaraddi S Belavagi; Young-Dae Gong; Imitiyaz Ahmed M Khazi
Journal:  Eur J Med Chem       Date:  2012-04-21       Impact factor: 6.514

3.  Molecular properties that influence the oral bioavailability of drug candidates.

Authors:  Daniel F Veber; Stephen R Johnson; Hung-Yuan Cheng; Brian R Smith; Keith W Ward; Kenneth D Kopple
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

4.  Synthesis and anticancer evaluation of bis(benzimidazoles), bis(benzoxazoles), and benzothiazoles.

Authors:  Shu-Ting Huang; I-Jen Hsei; Chinpiao Chen
Journal:  Bioorg Med Chem       Date:  2006-05-22       Impact factor: 3.641

5.  Rhodacyanine dyes as antimalarials. 1. Preliminary evaluation of their activity and toxicity.

Authors:  Kiyosei Takasu; Hiroshi Inoue; Hye-Sook Kim; Makoto Suzuki; Tadao Shishido; Yusuke Wataya; Masataka Ihara
Journal:  J Med Chem       Date:  2002-02-28       Impact factor: 7.446

6.  Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.

Authors:  Michael C Van Zandt; Michael L Jones; David E Gunn; Leo S Geraci; J Howard Jones; Diane R Sawicki; Janet Sredy; Jorge L Jacot; A Thomas Dicioccio; Tatiana Petrova; Andre Mitschler; Alberto D Podjarny
Journal:  J Med Chem       Date:  2005-05-05       Impact factor: 7.446

Review 7.  Zibotentan for the treatment of castrate-resistant prostate cancer.

Authors:  Dale R Shepard; Robert Dreicer
Journal:  Expert Opin Investig Drugs       Date:  2010-07       Impact factor: 6.206

8.  Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease.

Authors:  Srinivasan R Nagarajan; Gary A De Crescenzo; Daniel P Getman; Hwang Fun Lu; James A Sikorski; Jeffrey L Walker; Joseph J McDonald; Kathryn A Houseman; Geralyn P Kocan; Nandini Kishore; Pramod P Mehta; Christie L Funkes-Shippy; Lisa Blystone
Journal:  Bioorg Med Chem       Date:  2003-11-03       Impact factor: 3.641

9.  Synthesis and antimicrobial activity of new 4-thiazolidinone derivatives containing 2-amino-6-methoxybenzothiazole.

Authors:  Navin B Patel; Faiyazalam M Shaikh
Journal:  Saudi Pharm J       Date:  2010-06-02       Impact factor: 4.330

10.  Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A(2A) Receptors for the Treatment of Parkinson's Disease.

Authors:  Faizul Azam; Arwa M Madi; Hamed I Ali
Journal:  J Young Pharm       Date:  2012-07
View more
  1 in total

Review 1.  Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives.

Authors:  Teresa Glomb; Piotr Świątek
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.